HealthyGIFANCT01454219
Measurement of Glycaemic Responses of Bakery and Confectionery Products
A study testing Bakery and confectionary products in people with Healthy, run by Clinical Life Sciences Ltd. at 1 site in Finland.
Trial summary
This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Bakery and confectionary products
- How many people
- 14 participants
- Where
- 1 siteFinland
- Study dates
- Aug 2011to Jan 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- voluntarily given written consent for participation in research
- healthy man or women, age between 18 ang 65 years
- regular eating
- Body Mass Index 18,5 - 24,9 kg/m2
Who cannot join
- diabetes
- gastrointestinal diseases
- hepatic, kidney, pancreas or thyroid disease or disorder
- arthritis
- pregnancy or breast feeding
- smoking
Show all 9Show fewer
- allergy
- severe diseases
- blood donation
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.
- Conditions
- Healthy
- Being tested
- Bakery and confectionary products
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Bakery and confectionary productsOther
Control product: Glucose solution, Test products: 11 bakery and confectionary products
What is being measured
The primary outcome is the main question the study is designed to answer.
Glycemic index (GI)
The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).
Secondary outcomes (2)
Insulin index (II)
The 2 hours insulinemic responses to bakery and confectionery products (the incremental area under the insulin response curve, IAUC).
Glycemic load (GL)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2011 (estimated)
- Study startAug 2011
- Primary completionJan 2012
- Study completionJan 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 14 participants (actual)
Sponsor and investigators
- Lead sponsor
- Clinical Life Sciences Ltd.
- Sponsor type
- University, hospital or other
- Collaborators
- Fazer
- Responsible party
- Sponsor
- Investigators
- Päivi Cheney, MD, Principal investigatorTiina Suutari, M.Sc., Study director, Clinical Life Sciences Ltd.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01454219
- Sponsor's protocol ID
- GIFA
- Acronym
- GIFA
- Status last verified
- Nov 2011
- First submitted
- 14 Oct 2011
- Last updated
- 15 Feb 2012
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Feb 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measurement of Glycaemic Responses of Bakery and Confectionery Products
- ClinicalTrials.gov ID
- NCT01454219
- Acronym / sponsor ID
- GIFA / GIFA
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 14 participants (actual)
- Lead sponsor
- Clinical Life Sciences Ltd.University, hospital or other
- Collaborators
- Fazer
- Study start
- Aug 2011
- Primary completion
- Jan 2012 (actual)
- Study completion
- Jan 2012 (actual)
- First posted
- 18 Oct 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to determine the glycemic index, glycemic load and insulin index of eleven Fazer bakery and confectionary products.
Study design
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- voluntarily given written consent for participation in research
- healthy man or women, age between 18 ang 65 years
- regular eating
- Body Mass Index 18,5 - 24,9 kg/m2
Key exclusion criteria (9 listed)
- diabetes
- gastrointestinal diseases
- hepatic, kidney, pancreas or thyroid disease or disorder
- arthritis
- pregnancy or breast feeding
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Bakery and confectionary productsControl product: Glucose solution, Test products: 11 bakery and confectionary products | Other | – |
Primary outcome
Glycemic index (GI)
The 2 hours glycemic responses to bakery and confectionery products (the incremental area under the glucose response curve, IAUC).
2 secondary outcomes
Insulin index (II)
Glycemic load (GL)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Feb 2012.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Päivi Cheney, MD principal investigator
Tiina Suutari, M.Sc. study director
Clinical Life Sciences Ltd.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Bakery and confectionary products in people with Healthy, run by Clinical Life Sciences Ltd. at 1 site in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Feb 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Glycemic index (GI). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2012; AzTrials last refreshed its copy on 8 Nov 2026.